Precision Chroma is a University of Canterbury spin-out launched in January 2022 that makes patented 3D-printed chromatography columns under its Printed Monolith Adsorption (PMA) technology, used to purify biological medicines such as proteins, antibodies, vaccines and gene therapies. Its columns replace traditional packed-particle systems, cutting processing steps, time and cost in biopharmaceutical manufacturing. Headquartered in Christchurch, New Zealand, the company was incubated by Bridgewest Ventures and is part of Callaghan Innovation's Technology Incubator Programme, with operations across New Zealand and in Miami.
1
Round
1
Industry
4
Tags
Oct 11, 2026
Latest raise
Funding activity · 1 round
Oct 11, 2026
$7.3M
Seed
Led by M Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
